Nashville, Tenn.-based Vanderbilt University Medical Center has partnered with Bayer to advance therapeutics for the treatment of cardiovascular and kidney diseases.
The collaboration will last five years through an Investigational New Drug application, according to a Jan. 20 news release from VUMC.
The partnership aims to leverage clinical expertise and biological datasets alongside Bayer’s drug development portfolio to accelerate drug discovery, the release said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
